Updated risk assessments for sudden cardiac death in hypertrophic cardiomyopathy patients with implantable cardioverter-defibrillator

Hypertrophic cardiomyopathy (HCM) is a genetic disease associated with a risk of malignant ventricular tachyarrhythmias and sudden cardiac death (SCD). Assessment of the SCD risk is crucial for its clinical management, and there has been considerable interest in developing risk stratification strate...

Full description

Bibliographic Details
Main Author: Yae Min Park
Format: Article
Language:English
Published: The Korean Association of Internal Medicine 2023-01-01
Series:The Korean Journal of Internal Medicine
Subjects:
Online Access:http://kjim.org/upload/pdf/kjim-2022-144.pdf